Answers are grounded in this paper and cite their sources.
PURPOSE: Antibiotic irrigation of breast implants is widely used internationally, but no clinical study has investigated the pharmacokinetics in the breast implant pocket. In this prospective study, we determine how long locally applied gentamicin, cefazolin, and vancomycin maintain concentrations in the implant pocket above the minimum inhibitory concentration (MIC) for common infective bacteria and measure systemic uptake. METHODS: Patients undergoing implant-based breast reconstruction were recruited from the ongoing BREAST-AB trial, in which they were randomized to implant- and pocket irrigation with 160 µg/mL gentamicin, 2000 µg/mL cefazolin, and 2000 µg/mL vancomycin in a 200 mL saline solution or placebo at Rigshospitalet, Denmark. Samples from the breast drain and blood were obtained up to 10 days postoperatively. RESULTS: We included 40 patients who contributed with 146 drain samples and 66 blood samples between October 2021 and September 2022. Vancomycin and cefazolin remained above the MIC for S aureus significantly longer than gentamicin (gentamicin: 0.9 days versus vancomycin: 6.9 days, P<0.05, and cefazolin: 3.7 days, P<0.01). Gentamicin remained above the MIC for Pseudomonas aeruginosa for 1.3 days. Only cefazolin was detectable in blood samples, albeit in very low concentrations (median: 0.04 µg/mL). CONCLUSION: This study indicates that patients treated with triple-antibiotic implant irrigation during breast reconstruction receive adequate prophylaxis for S aureus and other common implant-associated gram-positive bacteria. However, the protection against P aeruginosa may be inadequate.
No takes yet. Share an insight, caveat, or question.
Hemmingsen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: